Literature DB >> 9583249

Vaccine coverage during a school-based hepatitis B immunization program.

S L Deeks1, I L Johnson.   

Abstract

Ontario initiated a universal hepatitis B immunization program for grade seven students in the fall of 1994. An ecological study was conducted within seven health units of the Greater Toronto Area to assess vaccine coverage. The study population consisted of all grade seven students enrolled within schools in the participating health units, on October 1, 1994. There were 39,935 students enrolled in 604 schools eligible for inclusion in the study. Consent to receive the vaccine series was obtained for 88% (range across health units from 81.5% to 96.3%) of the students. Among students for whom consent was obtained, an average of 95% (range 88.1% to 99.5%) completed the series. Therefore, the total vaccine coverage for the study population was 84% (range 77.5% to 89.5%). Series completion varied by school board, education provider and the use of Ministry of Health educational material. A limiting factor in achieving high vaccination coverage among grade seven students was obtaining consent to receive the vaccine series.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583249      PMCID: PMC6990316     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  9 in total

1.  A school-based hepatitis B immunization program for British Columbia, Canada.

Authors:  V Munroe
Journal:  J Sch Health       Date:  1996-08       Impact factor: 2.118

2.  Assessment of a universal, school-based hepatitis B vaccination program.

Authors:  S Dobson; D Scheifele; A Bell
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

3.  Report of the Hepatitis B Working Group.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1994-07-15

4.  Parents' attitudes toward school-based hepatitis B vaccination of their children.

Authors:  B A Woodruff; L Unti; K Coyle; L Boyer-Chuanroong
Journal:  Pediatrics       Date:  1996-09       Impact factor: 7.124

Review 5.  Hepatitis B: global importance and need for control.

Authors:  J E Maynard
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

Review 6.  Hepatitis B: the disease.

Authors:  S Sherlock
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

Review 7.  Serologic diagnosis of viral hepatitis.

Authors:  S Kumar; D C Pound
Journal:  Postgrad Med       Date:  1992-09-15       Impact factor: 3.840

8.  National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1993-07-30

9.  The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.

Authors:  J R Williams; D J Nokes; G F Medley; R M Anderson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

  9 in total
  3 in total

1.  [Evaluation of a program to promote hepatitis B vaccination among adolescents in a school environment of Central Montreal].

Authors:  A Bruneau; N Haley; L Valiquette
Journal:  Can J Public Health       Date:  2001 Sep-Oct

2.  Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada.

Authors:  Carla Osiowy; Elizabeth Giles; Max Trubnikov; Yogesh Choudhri; Anton Andonov
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 3.  Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.

Authors:  K E Gallagher; E Kadokura; L O Eckert; S Miyake; S Mounier-Jack; M Aldea; D A Ross; D Watson-Jones
Journal:  BMC Public Health       Date:  2016-02-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.